An ELISA method for detection of human antibodies to an immunotoxin

Journal of Pharmacological and Toxicological Methods

Volumn 47, Issue 3, 2002, Pages 169-175

  Benbrook, Doris M ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Antibodies; ELISA; Exotoxin; Immunotoxin; Mesothelin; Methods; Pseudomonas; Serum

Indexed keywords

ANTIBODY; AVIDIN; BENZIDINE DERIVATIVE; BIOTIN; HORSERADISH PEROXIDASE; IMMUNOTOXIN; IMMUNOTOXIN ANTIBODY; TETRAMETHYL BENZIDINE; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ARTICLE; CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GOAT; HUMAN; OPTICAL DENSITY;

ARMORACIA RUSTICANA; CAPRA HIRCUS; MURINAE; PSEUDOMONAS; PSEUDOMONAS EXOTOXIN;

EID: 0036589687     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(02)00232-0     Document Type: Article

References (11)

1. Argani P., Iacobuzio-Donahue C., Ryu B., Rosty C., Goggins M., Wilentz R.E., Murugesan S.R., Leach S.D., Jaffee E., Yeo C.J., Cameron J.L., Kern S.E., Hruban R.H. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clinical Cancer Research. 7:2001;3862-3868.
2. Chang K., Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proceedings of the National Academy of Sciences of the United States of America. 93:1996;136-140.
3. Chang K., Pastan I., Willingham M.C. Frequent expression of the tumor antigen CAK1 in squamous-cell carcinoma. International Journal of Cancer. 51:1992;548-554.
4. Hassan R., Lerner M.R., Benbrook D.M., Lightfoot S.A., Brackett D.J., Wang Q.-C., Pastan I. Anti-tumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant anti-mesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro. Clinical Cancer Research. 8:2002;3520-3526.
5. Hassan R., Viner J.L., Wang Q.C., Margulies I., Kreitman R.J., Pastan I. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. Journal of Immunotherapy. 23:2000;473-479.
6. Hassan R., Wu C., Brechbiel M.W., Margulies I., Kreitman R.J., Pastan I. 111Indium-labeled monoclonal antibody K1: biodistribution study in nude mice bearing a human carcinoma xenograft expressing mesothelin. International Journal of Cancer. 80:1999;559-563.
7. Hwang J., Figzgerald D.J., Adhya S., Pastan I. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell. 48:1987;129-136.
8. Kreitman R.J. Toxin-labeled monoclonal antibodies. Current Pharmaceutical Biotechnology. 2:2001;313-325.
9. Kricka L.J. Human anti-animal antibody interferences in immunological assays. Clinical Chemistry. 45:1999;942-956.
10. Onda M., Nagata S., Tsutsumi Y., Vincent J.J., Wang Q., Kreitman R.J., Lee B.I.P. Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activity. Cancer Research. 61:2001;5070-5077.
11. Onda M., Willingham M., Wang Q., Kreitman R.J., Tsutsumi Y., Nagata S., Pasta I. Inhibition of TNF-α produced by Kupffer cells protects against the nonspecific liver toxicity of immunotoxin anti-Tac(Fv)-PE38, LMB-2. Journal of Immunology. 165:2000;7150-7156.